Home/Filings/5/0001104659-22-023334
5//SEC Filing

SILBER ALLAN C 5

Accession 0001104659-22-023334

CIK 0001811764other

Filed

Feb 13, 7:00 PM ET

Accepted

Feb 14, 6:52 PM ET

Size

10.4 KB

Accession

0001104659-22-023334

Insider Transaction Report

Form 5
Period: 2021-12-31
Transactions
  • Award

    Common Stock

    2021-06-30+313,884313,884 total(indirect: By Spouse)
  • Other

    Common Stock

    2021-06-3023,309514,778 total(indirect: By Trust)
Holdings
  • Common Stock

    4,218,605
  • Common Stock

    (indirect: Silber Holdings, Inc.)
    4,035,655
  • Common Stock

    (indirect: By LLC)
    71,744
Footnotes (5)
  • [F1]On June 30, 2021, POINT Biopharma Global Inc. (f/k/a Therapeutics Acquisition Corp., the "Issuer") consummated a business combination (the "Business Combination") pursuant to which Bodhi Merger Sub, Inc., a wholly-owned subsidiary of the Issuer, merged with and into POINT Biopharma Inc. ("Old POINT"). At the effective time of the Business Combination, each share of Old POINT outstanding as of immediately prior to the effective time was exchanged for shares of Common Stock of the Issuer based on an implied Old POINT vested equity value of $585,000,000. As a result, the Reporting Person's spouse received the reported shares of the Issuer's Common Stock in consideration for the equity securities of Old POINT held by the Reporting Person's spouse prior to the Business Combination. These shares held by the Reporting Person's spouse were inadvertently omitted from the Form 4 filed by the Reporting Person on June 30, 2021.
  • [F2]On June 30, 2021, the Reporting Person, as trustee, distributed 23,309 shares of the Issuer's Common Stock held pursuant to a trust to certain beneficiaries of that trust. This disposition was inadvertently omitted from the Form 4 filed by the Reporting Person on June 30, 2021.
  • [F3]Held in a trust for which the Reporting Person is the trustee.
  • [F4]Silber Holdings, Inc is a corporation controlled by the Reporting Person.
  • [F5]Anglian Holdings, LLC is a limited liability company solely owned by the Reporting Person.

Issuer

POINT Biopharma Global Inc.

CIK 0001811764

Entity typeother

Related Parties

1
  • filerCIK 0001009161

Filing Metadata

Form type
5
Filed
Feb 13, 7:00 PM ET
Accepted
Feb 14, 6:52 PM ET
Size
10.4 KB